Revolo Biotherapeutics Limited (“Revolo”) today announced that it will present two posters on its lead candidate, ‘1104, at the 2025 American Academy of Allergy Asthma and Immunology (AAAAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback